Published 2012-07-03
Devintha Tiza Ariani Rainy Umbas Nur Rasyid Tri Endah Suprabawati


Objective: To compare the effect the direction of catheter traction to the abdomen with direction to the leg on hemostasis and pain degree post-TURP. Material & Method: 122 patients with BPH came to Cipto Mangunkusumo Hospital and Budi Asih Hospital, Jakarta during the period between January 2005 to January 2011. Results: 101 patients with retention and 21 patients without retention were included in this study. Resected tissue weight was 22,95 grams, irrigation time was 2,24 days, catheterisation time was 3,97 days, and post TURP hospitalization was 3,9 days. Hb decline was 1,17g/dl. There was no statistical difference on Hb decline between leg direction 1,23 g/dl and abdominal direction 1,12 g/dl. Resected tissue weight in abdominal direction group was 25 grams, while in leg direction group was 21 grams. Irrigation time in abdominal direction group was 2 days while in leg direction group was 2,4 days. Catheterisation time in abdominal direction group was 3,3 days while in leg direction was 3,4 days. Post TURP hospitalization in abdominal direction group was 3,7 days while in leg direction groups was 4,2 days. In this study resected tissue weight, irrigation time, catheterisation time, and hospitalization time. There were 64 patients with pain degree registration, patients with abdominal traction had mean pain degree scale 1,52 and 33 patients with leg traction had pain degree scale 2,97, in this study this differences were significant. Conclusion: Abdominal traction post TURP was statistically difference on shortened postoperative irrigation and catheterisation time, including reduced post TURP hospitalization and pain degree. Abdominal traction was recommended from this study to be used as the reference standard for changing leg traction. Keywords: Catheter traction, visual analog scale, hemostasis, transurethral resection of the prostate.



Leveillee RJ, Patel VR. Benign prostate hyperplasia [Online]. 2009 June 8 [cited 2010 March 10]; Available from URL:

Roehrborn CG, McConnell JD. Benign prostatic hyperplasia: Etiology, pathophysiology, epidemiology, and natural history. In: Wein AJ, Kavoussi LR, Partin AW, Peters AC, Novick AC, editors. Prostate. Campbell’s Urology. 9th ed. Philadelphia: Saunders Elsevier; 2007. p. 2727-66.

Barry MJ. Epidemiology and natural history of benign prostatism in four countries. Eur Urol. 1996; 29: 15–20.

Rahardjo D. Prostat: Kelainan–kelainan jinak, diagnosis, dan penanganan. Jakarta: Asian Medical; 1999.

Speakman MJ, Kirby RS, Joyce A, Abrams P, Pocock R. Guidelines for the primary care management of male lower urinary tract symptoms. BJU Int. 2004; 93: 985-90.

Fadlol A, Umbas R, Muslim P, Rasyid N. Pengaruh arah traksi kateter terhadap hemostasis pasca reseksi prostat transuretra (studi pendahuluan). J I Bedah Indonesia. 2006; 34(1): 15-8.

AUA Practice Guidelines Committee. AUA Guideline on Management of Benign Prostatic Hyperplasia. J Urol. 2003; 170: 530-47.

Hardjowijoto S, Taher A, Poernomo BB, Umbas R, Sugandi S, Rahardjo D, et al. Pedoman penatalaksanaan BPH di Indonesia. Surabaya: IAUI; 2003.

Kaplan SA. Transurethral resection of the prostate-Is our gold standard still a precious commodity? J Urol. 2008; 180: 15-6.

Zulian RAS, Piedade KE, Brito RR, Borges HJ, Guerra LAC, Bresler RRB. Transurethral prostatectomy: Review of 1,000 patients using distilled water as irrigating fluid and the suprapubic shunt. Braz J Urol. 2001; 27(3): 215-21.

Bryant JE, Bueschen AJ, Cohn JH, Nading AM, Transurethral prostatectomy: Analysis and comparison of four clinical series. South Med J. 1990; 83: 386-9.

Chen SS, Hong JG, Hsiao YJ, Chang LS. The correlation between clinical outcome and residual prostatic weight ratio after transurethral resection of the prostate for benign prostatic hyperplasia. BJU Int. 2000; 85: 79-82.

Oesterling JE. Abdominal catheter holder to maintain controlled urethral catheter tension post transurethal resection of prostate. Urology. 1992; 40(3): 206-10.

Yantoro AT. Efek Ketorolak 30 mg intravena sebagai preemptive analgesia pada operasi removal implant bedah orthopedi: Laporan pendahuluan [Tesis]. Yogyakarta: Fakultas Kedokteran Universitas Gajah Mada; 2009.

Ekengren J, Haendler L, Hahn RG. Clinical outcome 1 year after transurethral vaporization and resection of the prostate. Urology. 2000; 55: 231-5.

Uchida T, Ohori M, Soh S, Sato T, Iwamura M, Teruaki AO. Factors influencing morbidity in patients undergoing transurethral resection of the prostate. Urology. 1999; 53: 98-105.

Madersbacher S, Marberger M. Is transurethral resection of the prostate still justified? [Clinical paper review]. BJU Int. 1999; 83(3): 227-37.

Borboroglu PG, Kane CJ, Ward JF, Roberts JL, Sands JP. Immediate and postoperative complications of transurethral prostatectomy in the 1990s. Urology. 1999; 162: 1307-10.

Reich O, Gratzke CG, Bachman A, Seitz M, Schlenker B, Hermanek P, et al. Morbidity, mortality, and early outcome of transurethral resection of the prostate: A prospective multicenter evaluation of 10.654 patients. J Urol. 2008; 180: 246-9.

July 2012 Vol. 19 No. 2
Copyright Information
Department of Urology, Faculty of Medicine/Airlangga University